Diagnostic and Therapeutic Best Practices
These activities have been supported by independent educational grants from AstraZeneca
Anisha B. Dua, MD, MPH; Michael E. Wechsler, MD, MMSc
New Targeted Strategies to Reduce Disease Burdens
Michael E. Wechsler, MD, MMSc; Praveen Akuthota, MD; Anisha B. Dua, MD, MPH; Jason M. Springer, MD
Moving From Pathophysiology to Management
Jonathan M. Hand, MD; Professor Tom Wilkinson MA Cantab MBBS PhD FRCP FERS; Professor Dave Singh MD, FERS, FBPhS
Updates on the 2025 American College of Rheumatology Guidelines
Maria Dall’Era, MD